Core Viewpoint - The training session held in Shanxi Province aims to enhance quality management in the local liquor industry, specifically focusing on the development of the Fenjiu brand and its competitive edge through quality improvement [1] Group 1: Training Objectives and Content - The training session, themed "Strengthening Quality Foundations," was organized to unify the understanding of quality enhancement as a means to promote regional brand development [1] - Topics covered included legal regulations, quality management systems, product labeling, and interpretation of group standards [1] - Experts provided case studies to highlight operational risks and discussed the pathways for establishing quality management systems [1] Group 2: Industry Development and Support - The local market supervision bureau emphasized the importance of compliance and the dual role of service and regulation in supporting healthy industry development [1] - A commitment was made to establish quality improvement records for enterprises and to conduct ongoing support initiatives [1] - The goal is to continuously enhance the reputation of the "core production area of Qingxiang liquor" and empower sustainable industry development [1]

Core Viewpoint - The launch of the cross-regional quality enhancement project for the lithium battery new energy industry chain in five provinces aims to improve the resilience and safety of the supply chain while addressing regional barriers and homogenized competition [1] Group 1: Project Overview - The project is initiated by the State Administration for Market Regulation and the market regulation bureaus of Fujian, Jiangsu, Jiangxi, Sichuan, and Guizhou provinces [1] - The event is co-organized by the Fujian Provincial Quality Inspection Institute and the Ningde City Market Regulation Bureau, with support from Contemporary Amperex Technology Co., Limited (CATL) [1] Group 2: Objectives and Mechanisms - The project aims to establish a long-term mechanism for "resource sharing, complementary advantages, collaborative innovation, and service to the industry" [1] - It focuses on deepening cross-regional cooperation in quality enhancement for the lithium battery industry [1] Group 3: Collaborative Efforts - The five provincial market regulation departments will integrate resources and create a shared platform for inspection and testing [1] - There will be mutual recognition of testing data, complementary technical capabilities, and joint training of professional talent to support quality improvement in the industry [1] Group 4: Specific Initiatives - Ningde City will explore quality certification to promote high-quality development in the lithium battery industry, signing an agreement for carbon peak and carbon neutrality certification projects [1] - The Fujian Provincial Quality Inspection Institute will collaborate with CATL on technology research and standard development, establishing a national-level quality standard laboratory [1] - A joint laboratory for quality enhancement in the lithium battery new energy industry chain will be formed by the quality inspection institutes of the five provinces [1]

Overall Summary - The Anhui Provincial Market Supervision Administration released the results of the provincial quality supervision sampling inspection for 51 products, including shirts, functional clothing, and various household items, revealing that 82 out of 1496 batches were found to be non-compliant [3][4]. Group 1: Product Categories with Non-compliance - Shirts: Out of 50 batches inspected, 3 batches were non-compliant due to fiber content [4]. - Functional Clothing: Among 112 batches, 3 batches failed due to fiber content and hydrostatic pressure after washing [4]. - Underwear: 1 out of 62 batches was non-compliant due to fiber content [5]. - Wooden Furniture: 2 out of 12 batches were non-compliant due to woodworking requirements [6]. - Spring Mattresses: 3 out of 12 batches failed due to appearance performance (zipper) [6]. - Electrical Appliances: Various categories such as skin and hair care devices, small appliances, and lighting fixtures showed multiple non-compliance issues related to safety and performance standards [13][14][21]. Group 2: Specific Non-compliance Issues - Skin and Hair Care Devices: 3 batches failed due to protection against live parts, input power and current, and radiation interference [13]. - Small Appliances: 1 batch was non-compliant due to stability and mechanical hazards, and power connection issues [13]. - Lighting Fixtures: 10 out of 27 batches of fixed general lighting and 8 out of 27 batches of embedded lighting were found non-compliant due to various electrical interference and efficiency standards [14][15]. - Electrical Cables: 1 out of 112 batches failed due to insulation thickness issues [21]. Group 3: Additional Product Categories - Children’s Furniture: No non-compliance was found in 12 batches inspected [6]. - Household Gas Appliances: No non-compliance was reported in 12 batches of gas water heaters and stoves [19][20]. - Disposable Hygiene Products: Categories such as sanitary napkins, tissues, and diapers showed no non-compliance in their respective batches [15][16][17][18].

深秋的蓉城，细雨微凉，成都高新区新川印小区内的热烈氛围却并未因此冲淡。10月31日，是新川印集中交付的首日，业主们如约而至，在为期3天的活动 中提前近5个月拿到新居钥匙。 在精心打造的归家园林中，撑着伞的业主们穿梭其间，水景在雨滴下更显灵动，经过雨水润泽的草木绿意愈浓。他们或驻足与家人规划未来，或在新家窗前 合影，现场洋溢着喜悦与期待。 新川印项目由华发股份、华润置地、鼎信长城共同打造。其中，作为与珠海经济特区同龄的综合性企业集团，华发股份以稳健的经营实力，为此次圆满交付 奠定坚实基础，也为市场观察房企如何兑现品质承诺提供了一个优秀参考答案。 稳健深耕，6年锻造高端改善名片 从珠海经济特区起步，华发集团1980年组建。作为集团旗下房地产板块的核心平台，华发股份在近年来房地产市场深度调整的背景下，展现出强劲的发展韧 性。 2019年，华发股份怀揣着对成都这座千年古都的敬意与期待，正式落子蓉城。6年来，企业始终秉持"聚焦核心地段，专筑高端改善"的发展战略，跟随成都 城市发展的重心，在锦江区、高新区、天府新区等高价值区域精耕细作。从首个项目华发统建锦江首府开始，到后来的锦江璞园、锦江大院、锦江上院、新 川印、阅天府 ...

Core Insights - The Zhongshan Market Supervision Administration conducted a food safety inspection covering eight categories of food, with a total of 213 samples tested, of which 205 were qualified and 8 were found to be unqualified [2]. Group 1: Inspection Results - A total of 213 food samples were collected from various food production and operation sectors in Zhongshan [2]. - Out of the 213 samples, 205 were deemed compliant, resulting in a compliance rate of approximately 96.3% [2]. - The unqualified samples included various food items, with specific violations noted in the inspection report [2]. Group 2: Consumer Engagement - The administration encourages consumers to actively participate in food safety supervision and report any harmful food products or illegal activities by calling the complaint hotline 12345 [2].

Core Points - The Zhongshan Market Supervision Administration conducted a food safety inspection covering seven categories of food, with a total of 214 batches tested, of which 206 were qualified and 8 were unqualified [2] Group 1: Inspection Overview - The inspection included categories such as catering food, condiments, convenience foods, pastries, cocoa and baked coffee products, edible agricultural products, and beverages [2] - The inspection was carried out according to the "Implementation Rules for Food Safety Supervision and Sampling Inspection in Guangdong Province" [2] Group 2: Results Summary - Out of 214 batches tested, 206 were found to be compliant, resulting in a compliance rate of approximately 96.3% [2] - The unqualified samples included various food items, with specific details provided in the attached inspection report [2] Group 3: Consumer Engagement - Consumers are encouraged to participate in food safety supervision and report any harmful food products or illegal activities to the Zhongshan Market Supervision Administration [2]

及其对照指纹图谱（ R ） 图15 批加味逍遥丸指纹图谱 维度升级：本项目研究将质量监控从单一指标升级为覆盖全方君臣佐使的"功效成分群"定量模式，来源 于君药（柴胡）、臣药（牡丹皮、栀子）及佐使药（白芍、甘草）的八种测定成分经证实与加味逍遥丸 疏肝清热等核心功效直接相关，标志着质量控制从"成分检测"迈向"功效关联"的科学新阶段。 近日，由同仁堂与北京中医药大学联合开展的加味逍遥丸质量评价研究取得重要成果。相关论文已在中 文核心期刊《西北药学杂志》正式收录，该项研究创新构建了"双维度指纹图谱-功效成分定量"质控新 模式，有效破解了中药复方多类型成分、尤其是弱紫外吸收核心成分同步检测的技术难题。 此项研究是同仁堂"守正创新"的典范，通过科技创新为百年古方注入现代科学内涵。新方法将为产品的 安全、有效与优质稳定提供更强技术保障，也为中药行业复方制剂的精准质控提供了创新性的"同仁堂 方案"。同仁堂将继续以科技赋能传统，以品质守护健康，助力中药产业高质量发展。 方法首创：成功利用HPLC-PDA-ELSD双检测器联用技术，首次实现对加味逍遥丸中紫外强吸收成分 （如栀子苷）与弱紫外吸收核心功效成分（如柴胡皂苷A、D）的同 ...

Core Viewpoint - The clinical study of Angong Jiangya Wan, conducted by a team from Capital Medical University and eight medical institutions, provides new evidence for the treatment of secondary hypertension with liver yang hyperactivity, highlighting its clinical value and application prospects [1]. Group 1: Blood Pressure Control Effect - The study, a multi-center, randomized, double-blind, placebo-controlled trial, included 240 patients and demonstrated a significant reduction in systolic/diastolic blood pressure by 15.58±10.16/9.72±7.41 mmHg, which is clinically meaningful for secondary hypertension patients [1]. - The blood pressure control rate reached 31.86%, validating the efficacy of Angong Jiangya Wan as an adjunct treatment for patients whose blood pressure remains uncontrolled after standard therapy [1]. Group 2: Symptom Improvement and Synergistic Effect - Angong Jiangya Wan showed a clinical improvement rate of up to 94.62% for core symptoms such as dizziness and headache, significantly outperforming the control group in both TCM syndrome scoring and quality of life scoring [2]. - The drug demonstrated stable synergistic effects when used in combination with mainstream treatment regimens, such as CCB+ARB and CCB+β-blockers, indicating its compatibility without the need to alter existing treatment frameworks [2]. Group 3: Safety and Academic Significance - No adverse events were reported during the trial, confirming the safety of Angong Jiangya Wan in combination therapy, which is crucial for long-term hypertension management [2]. - The study employs an internationally recognized evidence-based medicine approach to validate the efficacy of traditional Chinese medicine, providing a model for the modernization of TCM and the integration of Chinese and Western medicine in hypertension treatment [3].

同仁堂聚焦"满足行业需求的中药质控体系缺乏"的行业痛点，与北京中医药大学合作，在功效物质明 晰、质量控制指标筛选等方面建立了一系列专有技术和方法，系统阐明了大黄、人参等中药饮片所含的 化学成分以及体内代谢转化成分，进而精准表征了大黄蛰虫丸、人参养荣丸、人参健脾丸等中药复方的 物质基础，阐明了中药质量形成机理。通过内控标准提升和技术升级改造，促进了产品质量的进一步提 升。 近日，中华中医药学会公示了2025年度中华中医药学会科学技术奖评审结果。由北京中医药大学高晓燕 教授牵头，联合同仁堂等6家单位共同申报的《中药功效物质高效发现技术体系创新与产业化应用》项 目获科技进步三等奖。 阐明中药功效物质是构建中药整体质控标准体系、保障临床用药和产业发展的关键。几十年来，随着中 药现代化进程的发展，在中药功效成分研究领域取得了可喜进展，但依然无法克服其片面性、假阳性、 低效性等问题，制约了中药标准化和国际化。该项目是以中医药传承与创新发展的国家重大发展战略为 牵引，针对制约中药功效物质发现全面性和准确性的若干技术问题，朝向中药化学成分高效解析、功效 指标精准量化和功效物质准确辨识三个关键环节开展研究：利用高分辨质谱技术， ...

Core Insights - Beijing Tongrentang has made significant progress in the safety research of traditional Chinese medicine for depression, with results published in key journals [1][2] - The research provides scientific evidence for the clinical safety of medication for postpartum and adolescent depression patients, highlighting the importance of rational drug use [1][2] Group 1: Research Achievements - The studies on the safety of Baijitian oligosaccharide capsules were conducted in collaboration with the National Drug Safety Evaluation and Monitoring Center, focusing on non-clinical safety evaluations for nursing and juvenile animals [2] - The research involved administering doses up to 50 times the maximum daily human dosage, with no abnormal findings in various health indicators of the test animals, confirming the high safety of the capsules [2] Group 2: Product Development and Recognition - Baijitian oligosaccharide capsules, developed jointly with the Academy of Military Medical Sciences, are classified as a new type of traditional Chinese medicine and have received multiple invention patents and the First Prize for Scientific and Technological Progress in Beijing [1] - The product has been included in nine expert consensus and treatment guidelines, establishing it as a core therapeutic drug for mild to moderate depression [1] Group 3: Commitment to Safety and Innovation - The company emphasizes patient needs and adheres to strict standards in product quality, utilizing scientific methods to deepen safety research and ensure medication safety [2] - Beijing Tongrentang's long-standing philosophy of meeting health needs continues to drive innovation in traditional Chinese medicine, contributing to the high-quality development of mental health services in China [2]